Oasis Medical Recalls ImproVue Ophthalmic Drops for pH Specification Failure
Oasis Medical is recalling 909 cartons of ImproVue Ophthalmic Lubricant Drops due to a failure to meet pH specifications. The affected lot was distributed in Florida.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or minor specification issues.
Plain-English summary
Oasis Medical, Inc. is recalling 909 cartons of ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose). The product is manufactured for OCULUS SURGICAL and is identified by NDC 62144-5510-05. The recall involves a specific lot with the code V0415F and an expiration date of 10/16.
The recall was initiated because the product failed to meet pH specifications. This is a Class III recall, which indicates that the violation is not likely to cause adverse health consequences. The affected units were distributed in Florida.
Consumers who have this specific lot of ImproVue Ophthalmic Lubricant Drops should stop using the product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- ImproVue Ophthalmic Lubricant Drops (1.7% Hypromellose), 1 Single Use Syringe, 0.07 fl oz (2mL), 1 Single Use Applicator Tip per carton, Manufactured for OCULUS SURGICAL, Port St. Lucie, FL 34986, NDC 62144-5510-05
- Manufacturer
- Oasis Medical, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 909
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # V0415F
- Exp 10/16
Distribution
Distributed in 1 state:
Related recalls
Same manufacturer · Oasis Medical, Inc.
See all →- SevereOasis Tears PF Lubricant Eye Drops Recalled for Sterility Assurance
FDA (Drugs) · 2026-05-20
- LowOasis Medical Recalls HPMC Visoelastic Topical Due to pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls HPMC Visoelastic Due to Potential pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls HPMC Visoelastic Due to pH Specification Failure
FDA (Drugs) · 2015-12-30
- LowOasis Medical Recalls ImproVue Ophthalmic Lubricant Drops for pH Failure
FDA (Drugs) · 2015-05-27
Same hazard · ph failure
See all →- ModerateDiclofenac topical gel recalled after failing pH specifications
FDA (Drugs) · 2026-01-28
- LowFerring Recalls Menopur Due to Out-of-Specification pH in Diluent
FDA (Drugs) · 2021-03-17
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-12-23
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-11-25